Literature DB >> 11735281

Effect of perfusion during ischemia on skeletal muscle.

T Tsuchida1, T Kato, M Yamaga, K Ikebe, Y Oniki, H Irie, K Takagi.   

Abstract

BACKGROUND: Despite the established preservation method for major organs of perfusion followed by immersion at hypothermia, a standard preservation technique for skeletal muscle is still a matter of controversy. The purpose of this study is to examine the effect of perfusion on the preservation of skeletal muscle in amputated limbs. MATERIALS AND
METHOD: The rat hindlimb was amputated for perfusion with Euro-Collins (EC) or University of Wisconsin (UW) solution at different perfusion pressures (40 or 100 cm-gravity). After certain ischemic periods (4 or 5 h), the skeletal muscle viability was determined by measuring the tissue content of adenosine triphosphate (ATP). RESULT: The UW solution perfusion group maintained better ATP levels than the EC solution group when the ischemic period was extended to 5 h. The perfusion pressure of 100 cm-gravity was more effective for preserving muscle viability than 40 cm-gravity with both EC and UW solutions.
CONCLUSION: UW solution might be adequate to preserve muscle viability and perfusion pressure is recommended at 100 cm-gravity rather than at minimal pressure (40 cm-gravity), which washes out stagnant blood.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11735281     DOI: 10.1006/jsre.2001.6278

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  2 in total

1.  Inhalation of carbon monoxide reduces skeletal muscle injury after hind limb ischemia-reperfusion injury in mice.

Authors:  Rajendra Patel; Hassan Albadawi; Wolfgang Steudel; Faraz F Hashmi; Jeanwan Kang; Hyung-Jin Yoo; Michael T Watkins
Journal:  Am J Surg       Date:  2012-04       Impact factor: 2.565

2.  Ischaemia-related cell damage in extracorporeal preserved tissue - new findings with a novel perfusion model.

Authors:  Christian D Taeger; Wibke Müller-Seubert; Raymund E Horch; Konstantin Präbst; Frank Münch; Carol I Geppert; Torsten Birkholz; Adrian Dragu
Journal:  J Cell Mol Med       Date:  2014-02-18       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.